1. Home
  2. CCEL vs CPHI Comparison

CCEL vs CPHI Comparison

Compare CCEL & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.53

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.55

Market Cap

26.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEL
CPHI
Founded
1989
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Managed Health Care
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
26.3M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
CCEL
CPHI
Price
$3.53
$0.55
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.2K
8.1K
Earning Date
04-14-2026
05-11-2026
Dividend Yield
4.26%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$25,384,279.00
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$353.33
N/A
Revenue Growth
9.76
N/A
52 Week Low
$2.72
$0.50
52 Week High
$5.52
$2.60

Technical Indicators

Market Signals
Indicator
CCEL
CPHI
Relative Strength Index (RSI) 49.49 36.52
Support Level $3.18 N/A
Resistance Level $3.57 $0.66
Average True Range (ATR) 0.29 0.04
MACD -0.03 -0.01
Stochastic Oscillator 17.39 8.45

Price Performance

Historical Comparison
CCEL
CPHI

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: